Loading...
XSWX
GALE
Market cap4.75bUSD
Apr 04, Last price  
82.10CHF
1D
1.11%
1Q
9.39%
IPO
90.93%
Name

Galenica AG

Chart & Performance

D1W1MN
No data to show
P/E
22.36
P/S
1.04
EPS
3.67
Div Yield, %
2.68%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
3.47%
Revenues
3.92b
+4.67%
2,826,272,0002,914,917,0003,008,851,0003,145,400,0003,171,342,0003,306,237,0003,479,753,0003,834,679,0004,014,348,0003,746,011,0003,921,081,000
Net income
183m
+5.39%
81,824,00081,122,00083,393,000118,804,000147,546,000124,992,000172,245,000167,680,000165,132,000173,598,000182,951,000
CFO
265m
+17.28%
84,118,000132,435,000156,818,000144,399,000173,550,000250,438,000224,360,000333,095,000236,873,000225,710,000264,703,000
Dividend
Apr 12, 20242.2 CHF/sh
Earnings
Apr 10, 2025

Profile

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
URL
https://www.galenica.com/
IPO date
Apr 07, 2017
Employees
7,673
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,921,081
4.67%
3,746,011
-6.68%
4,014,348
4.69%
Cost of revenue
2,916,662
3,470,668
3,779,887
Unusual Expense (Income)
NOPBT
1,004,419
275,343
234,461
NOPBT Margin
25.62%
7.35%
5.84%
Operating Taxes
30,898
29,245
33,767
Tax Rate
3.08%
10.62%
14.40%
NOPAT
973,521
246,098
200,694
Net income
182,951
5.39%
173,598
5.13%
165,132
-1.52%
Dividends
(110,173)
(110,266)
(104,443)
Dividend yield
2.97%
3.04%
2.78%
Proceeds from repurchase of equity
(5,596)
(6,063)
4,348
BB yield
0.15%
0.17%
-0.12%
Debt
Debt current
52,693
50,484
268,637
Long-term debt
419,083
421,598
417,853
Deferred revenue
183,005
Other long-term liabilities
557,511
609,230
17,008
Net debt
342,094
9,371
376,644
Cash flow
Cash from operating activities
264,703
225,710
236,873
CAPEX
(37,010)
(76,374)
(70,366)
Cash from investing activities
(151,083)
(124,167)
(130,621)
Cash from financing activities
(100,224)
(79,053)
(177,207)
FCF
785,293
283,546
156,984
Balance
Cash
129,682
116,159
93,927
Long term investments
346,552
215,919
Excess cash
275,410
109,129
Stockholders' equity
1,564,339
1,487,012
1,257,278
Invested Capital
2,345,243
1,993,757
1,803,472
ROIC
44.87%
12.96%
11.33%
ROCE
41.99%
12.13%
11.65%
EV
Common stock shares outstanding
49,886
49,895
49,804
Price
74.35
2.20%
72.75
-3.71%
75.55
10.21%
Market cap
3,709,041
2.18%
3,629,857
-3.53%
3,762,660
10.59%
EV
4,054,285
3,643,005
4,143,185
EBITDA
1,114,148
378,343
334,783
EV/EBITDA
3.64
9.63
12.38
Interest
12,654
15,809
5,508
Interest/NOPBT
1.26%
5.74%
2.35%